Hare
HomeInsights

INDUSTRY:

Pharma

TOPIC:

Business & People

TITLE:

European Commission Initiative Improves Information for Patients on Biosimilar Medicines

BRIEF:

 EFPIA, Biosimilar Medicines Group and EuropaBio issued a press release regarding the European Commission unique Q&A for patients with reliable information on biosimilar medicines. It is stated that stakeholders value these efforts to provide unbiased, scientifically correct and yet easy to understand information on biosimilar medicines through the Q&A on Biosimilar Medicines, now available in 7 EU languages.

LEGAL IMPLICATIONS:

BUSINESS IMPLICATIONS:

Special Report

In an unexpected move, just before the end of 2011, ...

Case Study

Improving expenditure efficiency has been, for a ver...

Your Portal Link to Mass Media Universe.

Valuable Quarterly Romanian Market Analysis.

Ask the analyst

Tailor-made advice for you

Feature Company